Icad Stock Quote Today

ICAD -  USA Stock  

USD 4.34  0.22  4.82%

Market Performance
3 of 100
Odds Of Distress
Less than 3
Icad is trading at 4.34 as of the 25th of June 2022, a -4.82 percent decrease since the beginning of the trading day. The stock's lowest day price was 4.26. Icad has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Icad Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2022 and ending today, the 25th of June 2022. Click here to learn more.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. The company has 25.11 M outstanding shares of which 1.1 M shares are currently shorted by private and institutional investors with about 5.03 trading days to cover. More on Icad Inc
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Icad Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Icad's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Icad or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Icad Inc has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 33.64 M. Net Loss for the year was (11.24 M) with profit before overhead, payroll, taxes, and interest of 24.56 M.
Icad Inc currently holds about 34.28 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Icad Inc has a poor financial position based on the latest SEC disclosures
Latest headline from www.streetinsider.com: Form DEF 14A Apyx Medical Corp For Dec 31 - StreetInsider.com
CEO and DirectorKenneth Ferry
Thematic IdeaMedical Equipment (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Icad report their recommendations after researching Icad's financial statements, talking to executives and customers, or listening in on Icad's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Icad Inc. The Icad consensus assessment is calculated by taking the average forecast from all of the analysts covering Icad.
Strong Buy4 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Icad Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Icad Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 4 - PoorDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares22.3 M24.8 M
Moderately Down
Slightly volatile
Weighted Average Shares Diluted22.3 M24.8 M
Moderately Down
Slightly volatile
Net Cash Flow from Operations(9.7 M)(9.4 M)
Fairly Down
Total Assets54.7 M62.2 M
Fairly Down
Total Liabilities18.4 M15.7 M
Fairly Up
Very volatile
Current Assets42.9 M50.3 M
Fairly Down
Slightly volatile
Current Liabilities14.6 M15 M
Fairly Down
Very volatile
Total Debt1.2 M1.2 M
Fairly Up
Slightly volatile
Gross Margin0.790.721
Significantly Up
Slightly volatile
Asset Turnover0.620.498
Fairly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Icad's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Icad's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Icad's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Icad's financial leverage. It provides some insight into what part of Icad's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Icad's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Icad deploys its capital and how much of that capital is borrowed.
Icad cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 1.16 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Icad Inc has a current ratio of 3.29, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Icad until it has trouble settling it off, either with new capital or with free cash flow. So, Icad's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Icad Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Icad to invest in growth at high rates of return. When we think about Icad's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(9.66 Million)Share
Icad Inc (ICAD) is traded on NASDAQ Exchange in USA. It is located in 98 Spit Brook Road, Suite 100, Nashua, NH 03062, United States and employs 136 people. Icad is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 114.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Icad's market, we take the total number of its shares issued and multiply it by Icad's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Icad Inc conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 25.11 M outstanding shares of which 1.1 M shares are currently shorted by private and institutional investors with about 5.03 trading days to cover. Icad Inc currently holds about 34.28 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check Icad Probability Of Bankruptcy
Icad Inc has a total of twenty-five million one hundred ten thousand outstanding shares. 30% of Icad Inc outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Icad Ownership Details

Icad Stock Price Odds Analysis

What are Icad's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Icad jumping above the current price in 90 days from now is about 6.68%. The Icad Inc probability density function shows the probability of Icad stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2598. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Icad will likely underperform. Additionally, the company has an alpha of 0.4016, implying that it can generate a 0.4 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 4.34HorizonTargetOdds Above 4.34
93.27%90 days
Based on a normal probability distribution, the odds of Icad to move above the current price in 90 days from now is about 6.68 (This Icad Inc probability density function shows the probability of Icad Stock to fall within a particular range of prices over 90 days) .

Icad Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Icad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Icad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Icad's value.
InstituionSecurity TypeTotal SharesValue
Granahan Investment Management LlcCommon Shares2.4 M10.6 M
Blackrock IncCommon Shares1.4 M6.1 M
View Icad Diagnostics

Icad Historical Income Statement

Icad Inc Income Statement is one of the three primary financial statements used for reporting Icad's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Icad Inc revenue and expense. Icad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Icad Research and Development Expense is projected to increase significantly based on the last few years of reporting. The past year's Research and Development Expense was at 9.19 Million. The current year Income Tax Expense is expected to grow to 1,026, whereas Consolidated Income is forecasted to decline to (12.1 M). View More Fundamentals

Icad Stock Against Markets

Picking the right benchmark for Icad stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Icad stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Icad is critical whether you are bullish or bearish towards Icad Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fund Screener Now


Fund Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Icad Corporate Directors

Icad corporate directors refer to members of an Icad board of directors. The board of directors generally takes responsibility for the Icad's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Icad's board members must vote for the resolution. The Icad board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Elliot Sussman - Independent DirectorProfile
Andrew Sassine - DirectorProfile
Somu Subramaniam - Independent DirectorProfile
Rakesh Patel - DirectorProfile

Investing Icad Inc

You need to understand the risk of investing before taking a position in Icad. The danger of trading Icad Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Icad is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Icad. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Icad Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.